Glaucoma is a group of eye diseases that damage the optic nerve, most often due to elevated or poorly tolerated eye pressure.

 

Open-angle glaucoma, the most common form, develops slowly as the eye’s drainage system becomes less efficient over time. Normal-tension glaucoma causes similar optic nerve damage despite eye pressures that fall within the normal range, making careful monitoring especially important. Angle-closure glaucoma occurs when the drainage angle becomes narrow or blocked, sometimes suddenly, leading to dangerous pressure spikes. Neovascular glaucoma is a more severe form caused by abnormal blood vessel growth, usually related to conditions like diabetes or retinal vein occlusion, and can be particularly difficult to treat.

​

The central principle of glaucoma care is lowering eye pressure, regardless of the specific type. Eye drops are often the first line of treatment and work by either reducing fluid production or improving drainage. Their effectiveness depends heavily on consistent daily use, which is one of the biggest challenges in glaucoma care. Laser treatments, such as selective laser trabeculoplasty or laser iridotomy in narrow angles, can improve drainage or prevent angle closure and may reduce or eliminate the need for drops in some patients.

​

When medications and laser are not sufficient, surgical options are considered. Minimally invasive glaucoma surgeries (MIGS) are often used in mild to moderate disease and aim to improve the eye’s natural drainage with a strong safety profile, frequently at the time of cataract surgery. In more advanced or aggressive cases, filtering surgeries such as trabeculectomy or tube shunt implantation create a new pathway for fluid to leave the eye and provide more substantial pressure lowering, though they require closer follow-up and carry higher risk.
 

Glaucoma is especially concerning because the vision loss it causes is irreversible. It typically affects peripheral vision first, meaning patients often do not notice symptoms until significant damage has already occurred. Importantly, glaucoma treatments do not restore lost vision—they are designed to prevent further damage. This makes long-term adherence to treatment and regular follow-up visits critical, even when vision seems stable. With early detection, consistent care, and close monitoring, glaucoma progression can often be slowed enough to preserve useful vision for life.